〇Defri Rizaldy1,2,3、Manami Toriyama1,2,4、Hiroko Kato1,2、Runa Fukui1,2、Fumitaka Fujita1,2,5、Motoki Nakamura1,6、Fumihiro Okada1,5、Akimichi Morita6、Ken J. Ishii2,7,8
(1.Lab. of Advanced Cosmetic Science, Grad. Sch. of Pharmaceutical Science, Osaka Univ.、2.Lab. of Mock Up Vaccine, Center for Vaccine and Adjuvant Research (CVAR), National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)、3.Dept. of Pharmaceutical Biology, Sch. of Pharmacy, Bandung Institute of Technology, Indonesia、4.Lab. of Molecular Signal Transduction, Grad. Sch. of Science and Technology, Nara Institute of Science and Technology (NAIST)、5.Mandom Corporation、6.Dept. of Geriatric and Environmental Dermatology, Grad. Sch. of Medical Science, Nagoya City Univ.、7.Lab. of Vaccine Science, Immunology Frontier Research Center (IFReC), Osaka Univ.、8.Div. of Vaccine Science, The Institute of Medical Science, The Univ. of Tokyo)
第43回日本分子生物学会年会